(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -38.12%571.7M | 12.42%1.75B | 43.10%923.85M | 80.88%1.56B | --645.62M | 86.27%861.17M | 85.80%553.02M | 101.76%462.32M | --297.64M | 515.84%229.14M |
Operating income | -38.12%571.7M | 12.42%1.75B | 43.10%923.85M | 80.88%1.56B | 645.62M | 86.27%861.17M | 85.80%553.02M | 101.76%462.32M | 297.64M | 515.84%229.14M |
Cost of sales | 39.44%-378.48M | -10.66%-1.16B | -42.06%-624.98M | -76.88%-1.05B | ---439.95M | -81.24%-593.93M | -79.92%-382.09M | -108.03%-327.7M | ---212.37M | -1,039.61%-157.53M |
Operating expenses | 39.44%-378.48M | -10.66%-1.16B | -42.06%-624.98M | -76.88%-1.05B | -439.95M | -81.24%-593.93M | -79.92%-382.09M | -108.03%-327.7M | -212.37M | -1,039.61%-157.53M |
Gross profit | -35.35%193.23M | 16.05%588.49M | 45.32%298.87M | 89.75%507.08M | 205.66M | 98.51%267.24M | 100.45%170.92M | 87.98%134.62M | 85.27M | 206.23%71.61M |
Selling expenses | 13.06%-79.29M | -31.86%-214.54M | -61.45%-91.19M | -40.29%-162.7M | ---56.48M | -91.98%-115.98M | -133.09%-91.41M | 20.48%-60.41M | ---39.22M | -267.37%-75.97M |
Administrative expenses | 49.25%-96.44M | -23.39%-406.62M | -0.44%-190.03M | 26.67%-329.53M | ---189.2M | -130.23%-449.38M | -148.18%-311.09M | -53.84%-195.19M | ---125.35M | -155.24%-126.87M |
Research and development expenses | 33.64%-148.04M | -8.04%-449.8M | -2.42%-223.1M | -27.04%-416.31M | ---217.83M | -80.51%-327.7M | -54.33%-176.53M | -60.23%-181.54M | ---114.39M | -295.02%-113.3M |
Impairment and provision | 32.95%-24.12M | -134.46%-86.8M | -62.73%-35.97M | -53.89%-37.02M | ---22.1M | -26.95%-24.06M | -303.88%-20.91M | -244.80%-18.95M | ---5.18M | -542.81%-5.5M |
-Impairment of intangible assets | ---9.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Goodwill impairment | ---9.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 87.38%-4.54M | -134.46%-86.8M | -62.73%-35.97M | -53.89%-37.02M | ---22.1M | -26.95%-24.06M | -303.88%-20.91M | -244.80%-18.95M | ---5.18M | -542.81%-5.5M |
Special items of operating profit | -218.86%-36.09M | -166.53%-30.73M | -21.37%30.36M | 70.95%46.2M | --38.61M | -22.04%27.02M | -36.98%13.38M | 23.52%34.66M | --21.23M | 300.93%28.06M |
Operating profit | 9.62%-190.75M | -52.95%-600.01M | 12.55%-211.05M | 37.02%-392.29M | -241.34M | -117.17%-622.84M | -133.98%-415.63M | -29.22%-286.8M | -177.63M | -219.19%-221.96M |
Financing income | -51.78%7.7M | -24.95%29.05M | -0.79%15.98M | 61.14%38.71M | --16.1M | 154.23%24.02M | 148.99%15.51M | -0.53%9.45M | --6.23M | 870.28%9.5M |
Financing cost | 16.43%-3.82M | -5.98%-8.57M | -123.68%-4.57M | 77.59%-8.09M | ---2.04M | 56.57%-36.1M | 33.66%-35.32M | -133.46%-83.11M | ---53.25M | -1,276.07%-35.6M |
Earning before tax | 6.40%-186.87M | -60.24%-579.54M | 12.16%-199.65M | 43.04%-361.67M | -227.28M | -76.14%-634.92M | -93.83%-435.45M | -45.32%-360.46M | -224.65M | -248.66%-248.06M |
Tax | -35.54%2.32M | 1,709.18%9.26M | 224.84%3.59M | 346.15%512K | ---2.88M | -20.93%-208K | 69.23%-2.57M | 43.23%-172K | ---8.36M | -944.83%-303K |
After-tax profit from continuing operations | 5.87%-184.55M | -57.90%-570.27M | 14.82%-196.05M | 43.14%-361.16M | -230.16M | -76.11%-635.12M | -87.98%-438.02M | -45.21%-360.64M | -233.01M | -248.95%-248.36M |
Earning after tax | 5.87%-184.55M | -57.90%-570.27M | 14.82%-196.05M | 43.14%-361.16M | -230.16M | -76.11%-635.12M | -87.98%-438.02M | -45.21%-360.64M | -233.01M | -248.95%-248.36M |
Minority profit | 3,094.52%10.93M | 541.07%12.07M | -111.34%-365K | 27.59%1.88M | --3.22M | 305.22%1.48M | -230.13%-2.53M | 108.81%364K | --1.95M | -705.46%-4.13M |
Profit attributable to shareholders | 0.10%-195.48M | -60.40%-582.34M | 16.15%-195.69M | 42.97%-363.04M | -233.38M | -76.34%-636.6M | -85.35%-435.49M | -47.81%-361M | -234.96M | -245.63%-244.23M |
Basic earnings per share | 0.00%-0.36 | -59.09%-1.05 | 14.29%-0.36 | 53.85%-0.66 | -0.42 | 4.03%-1.43 | -5.10%-1.03 | -36.70%-1.49 | -0.98 | -186.84%-1.09 |
Diluted earnings per share | 0.00%-0.36 | -59.09%-1.05 | 14.29%-0.36 | 53.85%-0.66 | -0.42 | 4.03%-1.43 | -5.10%-1.03 | -36.70%-1.49 | -0.98 | -186.84%-1.09 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data